Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 2/2020

Open Access 01-12-2020 | Migraine | BRIEF COMMUNICATION

A longitudinal clinical and MRI evaluation of the treatment with erenumab

Authors: Alberto Coccia, Caterina Lapucci, Monica Bandettini di Poggio, Matteo Grazzini, Matilde Inglese, Cinzia Finocchi

Published in: Neurological Sciences | Special Issue 2/2020

Login to get access

Excerpt

Migraine is a very common neurologic disease second only to stroke for number of disability-adjusted life-years and, for the global disease burden [1]. Nowadays, there are several available preventive, abortive, and behavioral therapies for migraine, with different mechanisms of action (MoA). …
Literature
1.
Hershey AD (2017) CGRP The next frontier for migraine. N Engl J Med 377(22):2190–2191CrossRef
2.
Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA (2017) A controlled trial of erenumab for episodic Migraine. N Engl J Med 377(22):2123–2132CrossRef
Metadata
Title
A longitudinal clinical and MRI evaluation of the treatment with erenumab
Authors
Alberto Coccia
Caterina Lapucci
Monica Bandettini di Poggio
Matteo Grazzini
Matilde Inglese
Cinzia Finocchi
Publication date
01-12-2020
Publisher
Springer International Publishing
Keywords
Migraine
Erenumab
Published in
Neurological Sciences / Issue Special Issue 2/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04660-7

Other articles of this Special Issue 2/2020

Neurological Sciences 2/2020 Go to the issue

MIGRAINE AND PRIMARY HEADACHES

Other primary headaches. Cough headache, nummular headache and primary exercise headache: a secondary point of view

HEADACHES AND CEREBROVASCULAR DISEASE

Headache in cerebral venous thrombosis

MIGRAINE AND PRIMARY HEADACHES

Cluster headache and TACs: state of the art

THE SPECTRUM OF MIGRAINE COMORBIDITIES

Migraine and rare neurological disorders

BRIEF COMMUNICATION

Anti-CGRP monoclonal antibodies in cluster headache: what can we learn from recent clinical trials

BRIEF COMMUNICATION

Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center